<DOC>
	<DOCNO>NCT01895985</DOCNO>
	<brief_summary>The objective study evaluate effect latanoprostene bunod dose daily ( QD ) reduce intraocular pressure ( IOP ) measure 24-hour period healthy subject .</brief_summary>
	<brief_title>Efficacy Latanoprostene Bunod Lowering Intraocular Pressure Japanese Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Participants correct decimal visual acuity ( VA ) 0.5 good eye . Subjects know hypersensitivity contraindication latanoprostene bunod , ingredient study drug . Subjects know contraindication NO treatment . Subjects unable discontinue contact lens use least 7 day prior Visit 2 ( Day 0/1/2 ) 14 15day study treatment period . Subjects unable discontinue use topical ophthalmic medication , include artificial tear , least 7 day prior Visit 2 ( Day 0/1/2 ) 14 15day study treatment period . Subjects condition prevents reliable applanation tonometry either eye . Subjects glaucoma either eye . Subjects condition prevents clear visualization fundus . Subjects monocular . Subjects aphakia either eye . Subjects active corneal disease either eye . Subjects severe dry eye either eye . Subjects history/diagnosis clinically significant progressive retinal disease either eye . Subjects intraocular infection inflammation within 3 month ( 90 day ) prior Visit 1 ( Screening ) . Subjects history ocular laser surgery within 3 month ( 90 day ) prior Visit 1 ( Screening ) . Subjects history incisional ocular surgery severe trauma .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>